Literature DB >> 30302501

Ancestral and Compensatory Mutations that Promote Antiviral Resistance in Influenza N1 Neuraminidase Revealed by a Phylonumerics Approach.

Elma H Akand1, Kevin M Downard2.   

Abstract

Implementation of a new phylonumerics approach to construct a mass tree representing over 6000 H1N1 human influenza strains has enabled ancestral and compensatory descendant mutations to be identified in N1 neuraminidase that promote antiviral resistance and restore viral fitness. Adjacent to the H275Y resistance mutation site, mutations S299A and S247N, respectively, lead the evolution of oseltamivir-resistant strains and restore viral fitness to those strains thereafter. Importantly the mass tree phylonumerics approach can identify such mutations globally, without any positional bias, so that functionally linked or compensatory mutations remote in the sequence or structure of the protein can be identified and interrogated. This is achieved using mass map datasets commonly employed for protein identification in proteomics applications, thus avoiding the need for either gene or protein sequences that are central to other phylogenetic methods.

Entities:  

Keywords:  Antiviral resistance; Influenza; Mass spectrometry; Mutation; Neuraminidase; Phylogenetics

Mesh:

Substances:

Year:  2018        PMID: 30302501     DOI: 10.1007/s00239-018-9866-4

Source DB:  PubMed          Journal:  J Mol Evol        ISSN: 0022-2844            Impact factor:   2.395


  29 in total

1.  Clearcut: a fast implementation of relaxed neighbor joining.

Authors:  Luke Sheneman; Jason Evans; James A Foster
Journal:  Bioinformatics       Date:  2006-09-18       Impact factor: 6.937

2.  Mutational analysis employing a phylogenetic mass tree approach in a study of the evolution of the influenza virus.

Authors:  Elma H Akand; Kevin M Downard
Journal:  Mol Phylogenet Evol       Date:  2017-04-09       Impact factor: 4.286

3.  Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe.

Authors:  A Lackenby; O Hungnes; S G Dudman; A Meijer; W J Paget; A J Hay; M C Zambon
Journal:  Euro Surveill       Date:  2008-01-31

Review 4.  Surveillance trends of the 2009 influenza A(H1N1) pandemic in Europe.

Authors:  A Amato-Gauci; P Zucs; R Snacken; B Ciancio; V Lopez; E Broberg; P Penttinen; A Nicoll
Journal:  Euro Surveill       Date:  2011-06-30

5.  Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season.

Authors:  Tatiana Baranovich; Reiko Saito; Yasushi Suzuki; Hassan Zaraket; Clyde Dapat; Isolde Caperig-Dapat; Taeko Oguma; Iman Ibrahim Shabana; Takehiko Saito; Hiroshi Suzuki
Journal:  J Clin Virol       Date:  2009-12-03       Impact factor: 3.168

6.  Subtyping of the influenza virus by high resolution mass spectrometry.

Authors:  Alexander B Schwahn; Jason W H Wong; Kevin M Downard
Journal:  Anal Chem       Date:  2009-05-01       Impact factor: 6.986

7.  Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase.

Authors:  J N Varghese; P W Smith; S L Sollis; T J Blick; A Sahasrabudhe; J L McKimm-Breschkin; P M Colman
Journal:  Structure       Date:  1998-06-15       Impact factor: 5.006

Review 8.  Mutations of neuraminidase implicated in neuraminidase inhibitors resistance.

Authors:  Olivier Ferraris; Bruno Lina
Journal:  J Clin Virol       Date:  2007-12-11       Impact factor: 3.168

9.  Efficient transmission of pandemic H1N1 influenza viruses with high-level oseltamivir resistance.

Authors:  Christopher W Seibert; Saad Rahmat; Florian Krammer; Peter Palese; Nicole M Bouvier
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

10.  Enzymatic properties of the neuraminidase of seasonal H1N1 influenza viruses provide insights for the emergence of natural resistance to oseltamivir.

Authors:  Marie-Anne Rameix-Welti; Vincent Enouf; Frédérique Cuvelier; Patricia Jeannin; Sylvie van der Werf
Journal:  PLoS Pathog       Date:  2008-07-25       Impact factor: 6.823

View more
  2 in total

Review 1.  Why Glycosylation Matters in Building a Better Flu Vaccine.

Authors:  Deborah Chang; Joseph Zaia
Journal:  Mol Cell Proteomics       Date:  2019-10-11       Impact factor: 5.911

2.  Analysis of bacterial biotyping datasets with a mass-based phylonumerics approach.

Authors:  Christian Mann; Kevin M Downard
Journal:  Anal Bioanal Chem       Date:  2022-03-06       Impact factor: 4.478

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.